Bone marrow at1 augments neointima formation by promoting mobilization of smooth muscle progenitors via platelet-derived sdf-1α

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 1, 2010, Pages 60-67

  Yokoi, Hirokazu ^a   Yamada, Hiroyuki ^a   Tsubakimoto, Yoshinori ^a   Takata, Hiroki ^a   Kawahito, Hiroyuki ^a   Kishida, Sou ^a   Kato, Taku ^a   Matsui, Akihiro ^a   Hirai, Hideyo ^b   Ashihara, Eishi ^b   Maekawa, Taira ^b   Iwai, Masaru ^c   Horiuchi, Masatsugu ^c   Ikeda, Kouji ^a   Takahashi, Tomosaburo ^a   Okigaki, Mitsuhiko ^a   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin; Bone marrow progenitors; Neointima formation; Platelet; Stromal cell derived factor 1

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; THROMBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; BONE MARROW; CELL HOMING; CHIMERA; CONTROLLED STUDY; FEMORAL ARTERY; INTIMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; THROMBOCYTE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIBODIES; BLOOD PLATELETS; BONE MARROW; CELL LINEAGE; CHEMOKINE CXCL12; ENDOTHELIAL CELLS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCLE, SMOOTH, VASCULAR; PLATELET AGGREGATION; RECEPTOR, ANGIOTENSIN, TYPE 1; TUNICA INTIMA;

EID: 73849139724     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.192161     Document Type: Article

References (19)

1. Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T, Shimizu M, Komoda H, Node K. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: Impact on restenosis. Circulation. 2007;115:553-561.
2. + progenitors derived from embryonic stem cells differentiation into endothelial cells capable of vascular repair after arterial injury. Arterioscler Thromb Vasc Biol. 2006;26:2244-2251.
3. Schober A, Knarren S, Lietz M, Lin EA, Weber C. Crucial role of stromal cell-derived factor-1a in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation. 2003;108:2491-2497.
4. Zernecke A, Schober A, Bot I, Hundelshausen P, Liehn EA, Mopps B, Mericskay M, Gierschik P, Biessen EA, Weber C. SDF-1a/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res. 2005;96:784-791.
5. Shiba Y, Takahashi M, Yoshioka T, Yajima N, Morimoto H, Izawa A, Ise H, Hatake K, Motoyoshi K, Ikeda U. M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: The critical role of the SDF-1-CXCR4 system. Arterioscler Thromb Vasc Biol. 2007;27: 283-289.
6. Sakihara H, Masunaga T, Yamashita K, Hashimoto T, Inobe M, Todo S, Uede T. Stromal cell-derived factor-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis. Circulation. 2004;110: 2924-2930.
7. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, Hoffmann J, Urbich C, Lehmann R, Arenza-Seisdesdos F, Aicher A, Heeschen C, Fichtlscherer S, Zeiher AM, Dimmeler S. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res. 2005;97:1142-1151.
8. Zhang LN, Wilson DW, Cunha V, Sullivan ME, Vergona R, Rutledge JC, Wang YX. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1a in a mouse model of carotid artery ligation. Arterioscler Thromb Vasc Biol. 2006;26:765-772.
9. Paul M, Mehr AP, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86:747-803.
10. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007;292:C82-C97.
11. 2 receptors in neointimal formation. Circulation. 2002; 106:847-853.
12. Ohtani K, Egashira K, Ihara Y, Naoko K, Funakoshi K, Zhao G, Sata M, Sunagawa K. Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells. Hypertension. 2006;48:664-670.
13. Yamada T, Kondo T, Numaguchi Y, Tsuzuki M, Matsubara T, Manabe I, Sata M, Nagai R, Murohara T. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. Arterioscler Thromb Vasc Biol. 2007;27:2363-2369.
14. Peter S, Trummel M, Meyners W, Koehler B, Westermann K. Valsartan versus ACE inhibition after bare metal stent implantation-results of the VALVACE trial. Int J Cardiol. 2005;98:331-335.
15. Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, Zohln-hoefer D, Hoppe K, Schiemann M, Kennerknecht E, Sauer S, Schulz C, Kerstan S, Rudelius M, Seidl S, Sorge F, Langer H, Peluso M, Goyal P, Vestweber D, Emambokus NR, Busch DH, Frampton J, Gawaz M. Platelets secrete stromal cell-derived factor 1 a and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med. 2006; 203:1221-1233.
16. Kalinowski L, Matys T, Chabielska E, Buczko W, Malinski T. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release. Hypertension. 2002;40:521-527.
17. Freedman JE. Translational therapeutics at the platelet vascular interface: Oxidative stress and platelets. Arterioscler Thromb Vasc Biol. 2008;28: s11-s16.
18. + cells to endothelial progenitor cells. Circulation. 2008;117:206-215.
19. Harada K, Komuro I, Sugaya T, Murakami K, Yazaki Y. Vascular injury causes neointimal formation in angiotensin II type 1a receptor knockout mice. Circ Res. 1999;84:179-185.